PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors

A. M. Canudas, V. Di Giorgi-Gerevini, L. Iacovelli, G. Nano, M. D'Onofrio, A. Arcella, F. Giangaspero, C. Busceti, L. Ricci-Vitiani, G. Battaglia, F. Nicoletti, Daniela Melchiorri

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Exposure of immature rat cerebellar granule cell cultures to the type 4 metabotropic glutamate (mGlu4) receptor enhancer N-phenyl-7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced [3H]thymidine incorporation. Its action was sensitive to the growth conditions and was attenuated by two mGlu4 receptor antagonists. An antiproliferative action of PHCCC was also seen in cultures from wild-type, but not mGlu4, knock-out mice. At least in rat cultures, PHCCC was not neurotoxic and enhanced neuritogenesis. Although PHCCC reduced the increase in cAMP formation and phospho-AKT levels induced by forskolin, none of these transduction pathways significantly contributed to the reduction of [3H]thymidine incorporation. Interestingly, PHCCC reduced the expression of Gli-1, a transcription factor that mediates the mitogenic action of Sonic hedgehog. Finally, we treated newborn rats with PHCCC either intracerebrally (infusion of 5 nmol/2 μl in the cerebellar region once every other day) or systemically (5 mg/kg, i.p., once daily) from postnatal days 3-9. Local infusion of PHCCC induced substantial changes in the morphology of the developing cerebellum. In contrast, systemic injection of PHCCC induced only morphological abnormalities of the cerebellar lobule V, which became visible 11 d after the end of the treatment. These data suggest that mGlu4 receptors are involved in the regulation of cerebellar development.

Original languageEnglish
Pages (from-to)10343-10352
Number of pages10
JournalJournal of Neuroscience
Volume24
Issue number46
DOIs
Publication statusPublished - Nov 17 2004

Fingerprint

Thymidine
Hedgehogs
Colforsin
Knockout Mice
Cerebellum
Transcription Factors
Cell Culture Techniques
Injections
Growth
metabotropic glutamate receptor 4
Therapeutics
N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide

Keywords

  • Cerebellar granule cell neuroprecursors
  • Development
  • Differentiation
  • PHCCC
  • Proliferation
  • Type 4 metabotropic glutamate receptor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors. / Canudas, A. M.; Di Giorgi-Gerevini, V.; Iacovelli, L.; Nano, G.; D'Onofrio, M.; Arcella, A.; Giangaspero, F.; Busceti, C.; Ricci-Vitiani, L.; Battaglia, G.; Nicoletti, F.; Melchiorri, Daniela.

In: Journal of Neuroscience, Vol. 24, No. 46, 17.11.2004, p. 10343-10352.

Research output: Contribution to journalArticle

@article{1153b36ea1284a6ab3dbbe811da8df16,
title = "PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors",
abstract = "Exposure of immature rat cerebellar granule cell cultures to the type 4 metabotropic glutamate (mGlu4) receptor enhancer N-phenyl-7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced [3H]thymidine incorporation. Its action was sensitive to the growth conditions and was attenuated by two mGlu4 receptor antagonists. An antiproliferative action of PHCCC was also seen in cultures from wild-type, but not mGlu4, knock-out mice. At least in rat cultures, PHCCC was not neurotoxic and enhanced neuritogenesis. Although PHCCC reduced the increase in cAMP formation and phospho-AKT levels induced by forskolin, none of these transduction pathways significantly contributed to the reduction of [3H]thymidine incorporation. Interestingly, PHCCC reduced the expression of Gli-1, a transcription factor that mediates the mitogenic action of Sonic hedgehog. Finally, we treated newborn rats with PHCCC either intracerebrally (infusion of 5 nmol/2 μl in the cerebellar region once every other day) or systemically (5 mg/kg, i.p., once daily) from postnatal days 3-9. Local infusion of PHCCC induced substantial changes in the morphology of the developing cerebellum. In contrast, systemic injection of PHCCC induced only morphological abnormalities of the cerebellar lobule V, which became visible 11 d after the end of the treatment. These data suggest that mGlu4 receptors are involved in the regulation of cerebellar development.",
keywords = "Cerebellar granule cell neuroprecursors, Development, Differentiation, PHCCC, Proliferation, Type 4 metabotropic glutamate receptor",
author = "Canudas, {A. M.} and {Di Giorgi-Gerevini}, V. and L. Iacovelli and G. Nano and M. D'Onofrio and A. Arcella and F. Giangaspero and C. Busceti and L. Ricci-Vitiani and G. Battaglia and F. Nicoletti and Daniela Melchiorri",
year = "2004",
month = "11",
day = "17",
doi = "10.1523/JNEUROSCI.3229-04.2004",
language = "English",
volume = "24",
pages = "10343--10352",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "46",

}

TY - JOUR

T1 - PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors

AU - Canudas, A. M.

AU - Di Giorgi-Gerevini, V.

AU - Iacovelli, L.

AU - Nano, G.

AU - D'Onofrio, M.

AU - Arcella, A.

AU - Giangaspero, F.

AU - Busceti, C.

AU - Ricci-Vitiani, L.

AU - Battaglia, G.

AU - Nicoletti, F.

AU - Melchiorri, Daniela

PY - 2004/11/17

Y1 - 2004/11/17

N2 - Exposure of immature rat cerebellar granule cell cultures to the type 4 metabotropic glutamate (mGlu4) receptor enhancer N-phenyl-7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced [3H]thymidine incorporation. Its action was sensitive to the growth conditions and was attenuated by two mGlu4 receptor antagonists. An antiproliferative action of PHCCC was also seen in cultures from wild-type, but not mGlu4, knock-out mice. At least in rat cultures, PHCCC was not neurotoxic and enhanced neuritogenesis. Although PHCCC reduced the increase in cAMP formation and phospho-AKT levels induced by forskolin, none of these transduction pathways significantly contributed to the reduction of [3H]thymidine incorporation. Interestingly, PHCCC reduced the expression of Gli-1, a transcription factor that mediates the mitogenic action of Sonic hedgehog. Finally, we treated newborn rats with PHCCC either intracerebrally (infusion of 5 nmol/2 μl in the cerebellar region once every other day) or systemically (5 mg/kg, i.p., once daily) from postnatal days 3-9. Local infusion of PHCCC induced substantial changes in the morphology of the developing cerebellum. In contrast, systemic injection of PHCCC induced only morphological abnormalities of the cerebellar lobule V, which became visible 11 d after the end of the treatment. These data suggest that mGlu4 receptors are involved in the regulation of cerebellar development.

AB - Exposure of immature rat cerebellar granule cell cultures to the type 4 metabotropic glutamate (mGlu4) receptor enhancer N-phenyl-7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced [3H]thymidine incorporation. Its action was sensitive to the growth conditions and was attenuated by two mGlu4 receptor antagonists. An antiproliferative action of PHCCC was also seen in cultures from wild-type, but not mGlu4, knock-out mice. At least in rat cultures, PHCCC was not neurotoxic and enhanced neuritogenesis. Although PHCCC reduced the increase in cAMP formation and phospho-AKT levels induced by forskolin, none of these transduction pathways significantly contributed to the reduction of [3H]thymidine incorporation. Interestingly, PHCCC reduced the expression of Gli-1, a transcription factor that mediates the mitogenic action of Sonic hedgehog. Finally, we treated newborn rats with PHCCC either intracerebrally (infusion of 5 nmol/2 μl in the cerebellar region once every other day) or systemically (5 mg/kg, i.p., once daily) from postnatal days 3-9. Local infusion of PHCCC induced substantial changes in the morphology of the developing cerebellum. In contrast, systemic injection of PHCCC induced only morphological abnormalities of the cerebellar lobule V, which became visible 11 d after the end of the treatment. These data suggest that mGlu4 receptors are involved in the regulation of cerebellar development.

KW - Cerebellar granule cell neuroprecursors

KW - Development

KW - Differentiation

KW - PHCCC

KW - Proliferation

KW - Type 4 metabotropic glutamate receptor

UR - http://www.scopus.com/inward/record.url?scp=20844457754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20844457754&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3229-04.2004

DO - 10.1523/JNEUROSCI.3229-04.2004

M3 - Article

C2 - 15548648

AN - SCOPUS:20844457754

VL - 24

SP - 10343

EP - 10352

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 46

ER -